Long-acting treatments to prevent HIV transmission
LASER ART for PreP
This study is working on new long-lasting HIV prevention treatments that could help people take their medicine just once a year instead of every day, making it easier to stay healthy and avoid HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11056688 on NIH RePORTER |
What this research studies
This research focuses on developing innovative long-acting antiretroviral therapies (LASER ART) aimed at preventing HIV transmission. By utilizing advanced pharmacologic and virologic methods, the project seeks to create medications that can be administered less frequently, potentially only once a year, compared to daily pills. The approach involves extensive collaboration among experts to enhance drug effectiveness and adherence, targeting viral reservoirs in the body. Patients may benefit from a more convenient and effective way to prevent HIV infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk of HIV exposure who are seeking effective prevention methods.
Not a fit: Patients who are already living with HIV or those who do not have risk factors for HIV exposure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with a long-lasting and more convenient method to prevent HIV infection.
How similar studies have performed: Previous research has shown promise in developing long-acting antiretroviral therapies, indicating a potential for success in this innovative approach.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Gendelman, Howard E — University of Nebraska Medical Center
- Study coordinator: Gendelman, Howard E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.